Gonadoblastoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{Sahar}}
{{CMG}}; {{AE}} {{Sahar}}
==Overview==
==Overview==
Gonadoblastoma per se is a benign tumor, however, it has the capacity to convert to [[dysgerminoma]] or other more malignant [[Germ cell tumor|germ cell tumors]] and produce steroids with resultant [[virilization]]. Prognosis is generally excellent after removing the tumor.  
Gonadoblastoma per se is a [[benign tumor]], however, it has the capacity to convert to [[dysgerminoma]] or other more [[malignant]] [[Germ cell tumor|germ cell tumors]] and produce [[steroids]] with resultant [[virilization]]. [[Prognosis]] is generally excellent after removing the [[tumor]].
 
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural History===
===Natural History===
*The gonadoblastoma usually develop in the first and second decade of life.<ref name="978-1-4557-4858-7">{{cite book | last = Sperling | first = M | title = Pediatric endocrinology | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2014 | isbn = 978-1-4557-4858-7 }}</ref> If complicated by an invasive germ cell tumor, then prognosis depends on the staging of the tumor.<ref name="978-0-323-40067-1">{{cite book | last = Saia | first = Philip | title = Clinical gynecologic oncology | publisher = Elsevier | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-40067-1 }}</ref>
*Gonadoblastoma usually develops in the first and second decades of life.<ref name="978-1-4557-4858-7">{{cite book | last = Sperling | first = M | title = Pediatric endocrinology | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2014 | isbn = 978-1-4557-4858-7 }}</ref>
*It is usually diagnosed during a workup for sex organ developmental disorders, primary amenorrhea and or virilization.   
*If complicated by an [[invasive]] [[germ cell tumor]], then [[prognosis]] depends on the [[Staging (pathology)|staging]] of the [[tumor]].<ref name="978-0-323-40067-1">{{cite book | last = Saia | first = Philip | title = Clinical gynecologic oncology | publisher = Elsevier | location = Philadelphia, PA | year = 2018 | isbn = 978-0-323-40067-1 }}</ref>
*It is usually diagnosed during a workup for [[sex organ]] developmental disorders, [[primary amenorrhea]], and/or [[virilization]].   
===Complications===
===Complications===
*Common complications of gonadoblastoma include:
*Common [[complications]] of gonadoblastoma include:<ref name="978-1-4557-4858-7">{{cite book | last = Sperling | first = M | title = Pediatric endocrinology | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2014 | isbn = 978-1-4557-4858-7 }}</ref>
**Dysgerminoma
**[[Dysgerminoma]]
**Seminoma
**[[Seminoma]]
**Other gonadal malignancies
**Other gonadal [[malignancies]]
 
===Prognosis===
===Prognosis===
*Prognosis is generally excellent if the tumor is removed by the time of diagnosis.
*[[Prognosis]] is generally excellent if the [[tumor]] is diagnosed and removed early.<ref name="urlPediatric Endocrinology | ScienceDirect">{{cite web |url=https://www.sciencedirect.com/book/9781455748587/pediatric-endocrinology |title=Pediatric Endocrinology &#124; ScienceDirect |format= |work= |accessdate=}}</ref>
*Depending on the presence of the coexisting germinal tumors at the time of diagnosis, the prognosis may vary.  
*Depending on the presence of the coexisting germinal [[tumors]] at the time of [[diagnosis]], the [[prognosis]] may vary.
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 22: Line 26:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category:Medicine]]
[[Category:Oncology]]
[[Category:Gynecology]]
[[Category:Up-To-Date]]

Latest revision as of 21:54, 29 July 2020

Gonadoblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gonadoblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gonadoblastoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gonadoblastoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gonadoblastoma natural history, complications and prognosis

CDC on Gonadoblastoma natural history, complications and prognosis

Gonadoblastoma natural history, complications and prognosis in the news

Blogs on Gonadoblastoma natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Gonadoblastoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Gonadoblastoma per se is a benign tumor, however, it has the capacity to convert to dysgerminoma or other more malignant germ cell tumors and produce steroids with resultant virilization. Prognosis is generally excellent after removing the tumor.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

References

  1. 1.0 1.1 Sperling, M (2014). Pediatric endocrinology. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4557-4858-7.
  2. Saia, Philip (2018). Clinical gynecologic oncology. Philadelphia, PA: Elsevier. ISBN 978-0-323-40067-1.
  3. "Pediatric Endocrinology | ScienceDirect".

Template:WH Template:WS